Data is not available at this time.
Tenet Healthcare Corporation operates as a diversified healthcare services company, primarily focusing on acute care hospitals, outpatient facilities, and ambulatory surgery centers. The company generates revenue through patient care services, including surgical procedures, diagnostic imaging, and emergency care, supported by a fee-for-service model. Tenet serves a broad demographic across urban and suburban markets, leveraging its scale to negotiate favorable payer contracts and optimize operational efficiency. Its market position is strengthened by strategic acquisitions and partnerships, enhancing its footprint in high-growth regions. The healthcare sector remains highly competitive, with Tenet differentiating itself through integrated care delivery and technological advancements in patient management. The company’s focus on value-based care and cost containment aligns with industry trends toward efficiency and quality outcomes. Tenet’s diversified service portfolio mitigates reliance on any single revenue stream, providing resilience against regulatory or reimbursement fluctuations.
Tenet Healthcare reported revenue of $20.7 billion for FY 2024, with net income reaching $3.2 billion, reflecting strong profitability. Diluted EPS stood at $32.7, driven by operational efficiency and cost management. Operating cash flow of $2.0 billion underscores the company’s ability to convert earnings into liquidity, while capital expenditures of $931 million indicate ongoing investments in facility upgrades and technology.
The company’s earnings power is evident in its robust net income and EPS growth, supported by disciplined capital allocation. Tenet’s capital efficiency is reflected in its ability to generate substantial operating cash flow relative to expenditures, enabling debt reduction and strategic reinvestment. The absence of dividends suggests a focus on retaining earnings for growth initiatives and balance sheet optimization.
Tenet’s balance sheet shows $3.0 billion in cash and equivalents, providing liquidity for near-term obligations. Total debt of $13.2 billion remains a focus area, though the company’s strong cash flow generation supports deleveraging efforts. The financial health is further reinforced by manageable leverage ratios and access to capital markets for refinancing or growth opportunities.
Tenet has demonstrated consistent revenue growth, supported by organic volume increases and strategic acquisitions. The company does not pay dividends, opting instead to reinvest in high-return projects and debt reduction. Future growth is likely to be driven by expansion in outpatient services and partnerships with payers to enhance care coordination and cost efficiency.
The market values Tenet based on its earnings trajectory and operational improvements, with a current EPS of $32.7 reflecting strong investor confidence. Valuation multiples align with peers, considering the company’s growth prospects and sector dynamics. Expectations are tempered by macroeconomic factors such as labor costs and reimbursement pressures, though Tenet’s diversified model mitigates some risks.
Tenet’s strategic advantages include its scale, diversified service offerings, and focus on operational efficiency. The outlook remains positive, supported by industry tailwinds like aging demographics and increased demand for outpatient care. Challenges include regulatory uncertainty and cost inflation, but the company’s proactive management and strategic initiatives position it well for sustained performance.
10-K filings, investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |